BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 27525437)

  • 1. Lymphatic vessels regulate immune microenvironments in human and murine melanoma.
    Lund AW; Wagner M; Fankhauser M; Steinskog ES; Broggi MA; Spranger S; Gajewski TF; Alitalo K; Eikesdal HP; Wiig H; Swartz MA
    J Clin Invest; 2016 Sep; 126(9):3389-402. PubMed ID: 27525437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY; Hong SH; Shin M; Heo HR; Jang IH
    Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Lymphangiogenesis Shapes Tumor-Promoting Adipose Tissue Inflammation.
    Wagner M; Steinskog ES; Wiig H
    Am J Pathol; 2019 Oct; 189(10):2102-2114. PubMed ID: 31369756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
    Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
    J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.
    Harrell MI; Iritani BM; Ruddell A
    Am J Pathol; 2007 Feb; 170(2):774-86. PubMed ID: 17255343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma.
    Raica M; Jitariu AA; Cimpean AM
    Anticancer Res; 2016 Sep; 36(9):4427-35. PubMed ID: 27630278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
    Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
    Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage.
    Thomas SN; Rutkowski JM; Pasquier M; Kuan EL; Alitalo K; Randolph GJ; Swartz MA
    J Immunol; 2012 Sep; 189(5):2181-90. PubMed ID: 22844119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.
    Ruddell A; Croft A; Kelly-Spratt K; Furuya M; Kemp CJ
    BMC Cancer; 2014 May; 14():354. PubMed ID: 24886322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From tumor lymphangiogenesis to lymphvascular niche.
    Hirakawa S
    Cancer Sci; 2009 Jun; 100(6):983-9. PubMed ID: 19385973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
    Olmeda D; Cerezo-Wallis D; Riveiro-Falkenbach E; Pennacchi PC; Contreras-Alcalde M; Ibarz N; Cifdaloz M; Catena X; Calvo TG; Cañón E; Alonso-Curbelo D; Suarez J; Osterloh L; Graña O; Mulero F; Megías D; Cañamero M; Martínez-Torrecuadrada JL; Mondal C; Di Martino J; Lora D; Martinez-Corral I; Bravo-Cordero JJ; Muñoz J; Puig S; Ortiz-Romero P; Rodriguez-Peralto JL; Ortega S; Soengas MS
    Nature; 2017 Jun; 546(7660):676-680. PubMed ID: 28658220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors.
    Honkanen HK; Izzi V; Petäistö T; Holopainen T; Harjunen V; Pihlajaniemi T; Alitalo K; Heljasvaara R
    Neoplasia; 2016 Jul; 18(7):436-46. PubMed ID: 27435926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced lymphangiogenesis in cervical lymph nodes in oral melanoma-bearing mice.
    Ozasa R; Ohno J; Iwahashi T; Taniguchi K
    J Exp Clin Cancer Res; 2012 Oct; 31(1):83. PubMed ID: 23031500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response.
    Nakamura Y; Fujisawa Y; Okiyama N; Watanabe R; Tanaka R; Ishitsuka Y; Tahara H; Fujimoto M
    J Dermatol Sci; 2018 Apr; 90(1):46-51. PubMed ID: 29352630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice.
    Schlereth SL; Iden S; Mescher M; Ksander BR; Bosch JJ; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5965-73. PubMed ID: 26377082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A; Detmar M
    Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.